Case Report

Rare Systemic Dermatologic Reaction after Pneumococcal Vaccine Administration

Authors: Mack R. Holdiness, MD, PHD

Abstract

This case report describes a rare dermatologic reaction in a patient after administration of pneumococcal vaccine. A 65-year-old man developed an extensive dermatitis with pruritus, urticaria, and petechiae 1 week after receiving an intramuscular injection of the vaccine. The reaction resolved with application of topical steroids and oral diphenhydramine hydrochloride. This case report and others in the literature suggest the importance of recognizing the possibility of cutaneous adverse reactions with vaccines, such as the pneumococcal vaccine, which in general have a good safety profile.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med 2001; 161: 111–120.
 
2. Nichol KL, MacDonald R, Hauge M. Side effects associated with pneumococcal vaccination. Am J Infect Control 1997; 25: 223–228.
 
3. Centers for Disease Control and Prevention: Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989; 38 (5): 64–68, 73–76.
 
4. Rodriguez R, Dyer PD. Safety of pneumococcal revaccination. J Gen Intern Med 1995; 10: 511–512.
 
5. Ponka A, Leinonen M. Adverse reactions to polyvalent pneumococcal vaccine. Scand J Infect Dis 1982; 14: 67–71.
 
6. Overturf GD, Field R, Edmonds R. Death from type 6 pneumococcal septicemia in a vaccinated child with sickle-cell disease. N Engl J Med 1979; 300: 143.
 
7. Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999; 281: 243–248.
 
8. Holdiness MR. Adverse cutaneous reactions to influenza vaccinations and chemotherapy. Int J Dermatol 2001; 40: 427–430.
 
9. Nelson K, Goldman JA, Perlino CA. Severe local reactions to pneumococcal vaccine. South Med J 1980; 73: 264–265.
 
10. Hilleman MR, Carlson AJ Jr, McLean AA, et al:Streptococcus pneumoniae polysaccharide vaccine: Age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981; 3 (Suppl): S31–S42.
 
11. Kelton JG. Vaccination-associated relapse of immune thrombocytopenia. JAMA 1981; 245: 369–370.